Literature DB >> 17876108

Inducing mixed chimerism and transplantation tolerance through allogeneic bone marrow transplantation with costimulation blockade.

Ines Pree1, Thomas Wekerle.   

Abstract

Induction of mixed chimerism (i.e., coexistence of donor and recipient hematopoietic cells) through transplantation of allogeneic donor bone marrow under appropriate host conditioning, is one of the most reliable strategies to induce transplantation tolerance. Robust tolerance is evident in mixed chimeras as they permanently accept donor skin grafts while promptly rejecting third party grafts. Although historically, myeloablative and T-cell depleting regimens have been described, milder protocols involving costimulation blockade have recently been developed. The prototypical murine protocol described in this chapter, involves the use of CTLA4Ig and a monoclonal antibody-specific for CD154 (CD40L) for costimulation blockade, 3 Gy of nonmyeloablative total body irradiation and a conventional number of 20 x 10(6) fully allogeneic bone marrow cells. Flow cytometry is used to determine levels of multilineage hematopoietic chimerism and deletion of donor-reactive CD4+ T cells. Tolerance is assessed in vivo by grafting of donor and third party skin.

Entities:  

Mesh:

Year:  2007        PMID: 17876108     DOI: 10.1007/978-1-59745-395-0_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation.

Authors:  Sheng-Li Wu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

2.  Vascularized composite allotransplantation combined with costimulation blockade induces mixed chimerism and reveals intrinsic tolerogenic potential.

Authors:  Byoung Chol Oh; Georg J Furtmüller; Madeline L Fryer; Yinan Guo; Franka Messner; Johanna Krapf; Stefan Schneeberger; Damon S Cooney; W P Andrew Lee; Giorgio Raimondi; Gerald Brandacher
Journal:  JCI Insight       Date:  2020-04-09

3.  Efficacy of single-agent immunosuppressive regimens in a murine model of vascularized composite allotransplantation.

Authors:  Yinan Guo; Franka Messner; Byoung Chol Oh; Gerald Brandacher; Joanna W Etra; Sarah E Beck; Richa Kalsi; Georg J Furtmüller; Stefan Schneeberger
Journal:  Transpl Int       Date:  2020-05-12       Impact factor: 3.782

4.  Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Authors:  Eran Ophir; Noga Or-Geva; Irina Gurevich; Orna Tal; Yaki Eidelstein; Elias Shezen; Raanan Margalit; Assaf Lask; Guy Shakhar; David Hagin; Esther Bachar-Lustig; Shlomit Reich-Zeliger; Andreas Beilhack; Robert Negrin; Yair Reisner
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

5.  Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen.

Authors:  U Baranyi; N Pilat; M Gattringer; B Linhart; C Klaus; E Schwaiger; J Iacomini; R Valenta; T Wekerle
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

6.  Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.

Authors:  Ulrike Baranyi; Andreas M Farkas; Karin Hock; Benedikt Mahr; Birgit Linhart; Martina Gattringer; Margit Focke-Tejkl; Arnd Petersen; Fritz Wrba; Thomas Rülicke; Rudolf Valenta; Thomas Wekerle
Journal:  EBioMedicine       Date:  2016-03-20       Impact factor: 8.143

7.  Split Tolerance in a Murine Model of Heterotopic En Bloc Chest Wall Transplantation.

Authors:  Byoungchol Oh; Georg J Furtmüller; Veronika Malek; Madeline L Fryer; Cory Brayton; Piotr Walczak; Miroslav Janowsky; Gerald Brandacher; Amir H Dorafshar
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.